France pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$27.6 billion | 68.0% |
| 3002 Human blood | US$10.9 billion | 26.9% |
| 3006 Pharmaceutical goods | US$699.1 million | 1.7% |
| 3003 Medicaments | US$679.2 million | 1.7% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$364.2 million | 0.9% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$313.8 million | 0.8% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$19.2 billion | 47.3% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$6.0 billion | 14.7% |
| 300220 Vaccines: for human medicine | US$4.0 billion | 9.9% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$3.1 billion | 7.6% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$1.9 billion | 4.6% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$1.7 billion | 4.1% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$754.5 million | 1.9% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$629.3 million | 1.6% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$487.2 million | 1.2% |
| 300239 Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | US$454.0 million | 1.1% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$17.3 billion | 54.3% |
| 3002 Human blood | US$12.6 billion | 39.6% |
| 3006 Pharmaceutical goods | US$627.0 million | 2.0% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$617.9 million | 1.9% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$525.8 million | 1.7% |
| 3003 Medicaments | US$157.7 million | 0.5% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$12.4 billion | 39.1% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$9.9 billion | 31.2% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$2.5 billion | 7.8% |
| 300220 Vaccines: for human medicine | US$1.4 billion | 4.4% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$1.1 billion | 3.3% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$1.0 billion | 3.2% |
| 300190 Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | US$610.5 million | 1.9% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$419.8 million | 1.3% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$380.9 million | 1.2% |
| 300510 Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | US$274.4 million | 0.9% |
Shares are of France's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of France's trade.
More France products
- 27 Mineral fuels, mineral oils and products of their distillation
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 87 Vehicles
- 85 Electrical machinery and equipment and parts thereof
- 88 Aircraft, spacecraft, and parts thereof
- 33 Essential oils and resinoids
- 39 Plastics and articles thereof
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 22 Beverages, spirits and vinegar
- 71 Natural, cultured pearls
- 72 Iron and steel
- 73 Iron or steel articles
France pharmaceutical products: questions and answers
How much pharmaceutical products does France export?
In 2024, France exported US$40.6 billion of pharmaceutical products (HS chapter 30), 6.5% of its total exports. That ranks it 8 of 213 exporting countries in the data.
What are France's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$27.6 billion), Human blood (3002, US$10.9 billion), Pharmaceutical goods (3006, US$699.1 million).
How much pharmaceutical products does France import?
In 2024, France imported US$31.8 billion of pharmaceutical products (HS chapter 30), 4.3% of its total imports. That ranks it 9 of 226 importing countries in the data.
What are France's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$17.3 billion), Human blood (3002, US$12.6 billion), Pharmaceutical goods (3006, US$627.0 million).
